These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 912190)

  • 1. Chronic amphetamine administration and central dopamine receptor sensitivity [proceedings].
    Jenner P; Marsden CD; Pycock CJ
    Br J Pharmacol; 1977 Sep; 61(1):142P. PubMed ID: 912190
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d-amphetamine.
    Remington G; Anisman H
    Dev Psychobiol; 1976 Nov; 9(6):579-85. PubMed ID: 1001843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators].
    Novoselov IA; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
    Tyhon A; Lakaye B; Grisar T; Tirelli E
    Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced stereotypy: reply to Rebec and Bashore.
    Kokkinidis L; Anisman H
    Psychol Bull; 1983 Mar; 93(2):368-72. PubMed ID: 6682558
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
    Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
    Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
    Middaugh LD; Blackwell LA; Santos CA; Zemp JW
    Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
    Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
    J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of dopamine receptor sensitivity by estrogen.
    Gordon JH; Borison RL; Diamond BI
    Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 20. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
    Feigenbaum JJ; Yanai J; Blass RB
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.